Cargando…
Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease
BACKGROUND: Plasminogen activator inhibitor-1 (PAI-1) and soluble urokinase-type plasminogen activator receptor (suPAR) participate in inflammation and tissue remolding in various diseases, but their roles in chronic obstructive pulmonary disease (COPD) are not yet clear. This study aimed to investi...
Autores principales: | Wang, Hao, Yang, Ting, Li, Diandian, Wu, Yanqiu, Zhang, Xue, Pang, Caishuang, Zhang, Junlong, Ying, Binwu, Wang, Tao, Wen, Fuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044991/ https://www.ncbi.nlm.nih.gov/pubmed/27713627 http://dx.doi.org/10.2147/COPD.S107409 |
Ejemplares similares
-
Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary disease
por: Zhang, Xue, et al.
Publicado: (2016) -
Adipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease
por: Li, Diandian, et al.
Publicado: (2015) -
Diagnostic value of thyroid transcription factor-1 for pleural or other serous metastases of pulmonary adenocarcinoma: a meta-analysis
por: Shen, Yongchun, et al.
Publicado: (2016) -
Mechanism of KLF9 in airway inflammation in chronic obstructive pulmonary
por: Gu, Peijie, et al.
Publicado: (2023) -
Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD
por: Li, Diandian, et al.
Publicado: (2019)